Content Currently Unavailable
The Lipitor Warning for GLP-1 Drugmakers
Pfizer’s Lipitor experience shows the structural risks that today’s GLP-1 innovators may soon face
Content Currently Unavailable
False
Advertisement
Related Content
Industry News
Development & Clinical
Regulation & Standards
Can Clinical Trials Collect Less Data Without Compromising Safety?
October 22, 2026
5 min read
Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.
Outsourcing
Choosing a Sterile Fill-Finish Partner
October 22, 2026
5 min read
Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner
Drug Discovery
Development & Clinical
Interviews
How Genomics Is Personalizing Drug Discovery
October 20, 2026
4 min read
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
Facilities & Equipment
Inside Kindeva’s New Sterile Fill-Finish Facility
October 20, 2026
5 min read
John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through commercial manufacturing, and choosing a long-term fill-finish partner